Biotech - International Biopharmaceutical Industry

news

Adcendo Raises $135m for Cancer ADCs, and Other Financings

Adcendo has tapped into the strong investor appetite for companies developing antibody-drug conjugates for cancer with an oversubscribed second round that raised $13...

2 December 2024 news Adcendo | Antibody

Continue Reading →

news

Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its lead...

4 November 2024 news Biotech | GLP-1

Continue Reading →

news

SONOTEC presents extended non-contact flow meter series at Interphex

After successfully launching the SONOFLOW® CO.55 V3.0 flow meter last year, SONOTEC presents new sensor sizes to cover a wider range of biopharmaceutical applications...

11 April 2023 news bioprocessing applications | Biotech

Continue Reading →

news

Trial setback casts doubt on a biotech’s respiratory virus drug

Dive Brief: Enanta Pharmaceuticals’ pill to combat respiratory syncytial virus didn’t work in low-risk patients, with the company reporting Wednesday the antiviral...

22 May 2022 news Biotech | Drug

Continue Reading →

news

Vertex adds to Boston expansion with plans for new site

Dive Brief: Fresh off the dedication of a major new building in Boston’s Seaport, Vertex Pharmaceuticals said it’s making plans for yet another facility that it cl...

22 May 2022 news Biotech | Boston

Continue Reading →

news

Solid Bio joins slate of biotech layoffs, shedding 35% of its workforce

Dive Brief: Gene therapy developer Solid Biosciences is laying off 35% of its employees, announcing Wednesday a plan to extend its current funds for another two ye...

28 April 2022 news BIO | Biotech

Continue Reading →

news

Pfizer buys a private biotech and its RSV drug research

Dive Brief: Pfizer said Thursday it will spend as much as $525 million to buy the privately held biotech ReViral, adding experimental treatments for respiratory sy...

11 April 2022 news Biotech | Drug

Continue Reading →

news

As biotech retreats, gene therapy companies retrench and redraw plans

Bluebird bio has spent the better part of two decades developing gene therapies for rare diseases. This summer, after years of clinical trials, setbacks and delays, t...

25 March 2022 news Biotech | companies

Continue Reading →

news

Nektar, Bristol Myers drug combination fails in late-stage melanoma trial

Dive Brief: Shares in Nektar Therapeutics fell by more than half Monday morning after the San Francisco biotech company and partner Bristol Myers Squibb disclosed ...

21 March 2022 news Biotech | Bristol Myers

Continue Reading →

news

‘We have to make a stand’: Biotech leaders vow to break ties with Russia over Ukraine war

Hundreds of biotech leaders are pledging to stop working with Russian companies and to reject investment from Russian funds in response to the country's invasion of U...

14 March 2022 news Biotech | Russia

Continue Reading →